With a strong background on cellular biology, particularly in neurosciences, she is now deploing her know-how on the characterization of cells following bioprinting (e.g. cell viability, phenotype, metabolic product secretion, migration, proliferation, intercellular interactions and expression of key genes) key read-outs for the maturation process.
Passionate about the development and transfer of new technologies, Nathalie has managed R&D projects in industrial and academic settings. She oversaw cell-based product manufacturing and developed biofabrication processes and preclinical testing programs, in accordance with FDA, EMA, and international regulations. She is in charge of the ART cell team, manages the quality, and applies her knowledge to various projects. She enjoys bioprinting too!
Trained as a Mechanical Engineer from the University of Technology of Compiègne (UTC, France), he specialized in material science and biomaterials. He is currently working on bioink development, optimization, and characterization, for bioprinting applications.
She is a Biologist Engineer from the University of Technology of Compiègne (UTC, France) where she specialized in Biomaterials and Biomechanics, and later during an exchange program with U. Valparaiso (Chile) she gained expertise in Biomedical Engineering. Since then, she works on 3D bioprinting, especially on projects applying microextrusion.
With a background in fundamental physics, he worked firstly in ultrafast laser physics (high harmonic generation). He changed to applied optics in the field of biomedical engineering where he developed different prototypes. Currently, he combines this know-how for applications using laser-assisted bioprinting and laser-induced ablation.
With a background in the development of innovative molecular biology technique in the field of oncology, she decided to join the ART bioprint team . Integrated into ART’s Cell Biology pole, she divides her activity between the production and characterization of various cells used in printing projects (primary, tumor cell lines), and monitoring of post-printing models.
He is an oral surgeon specialized in translational models for tissue engineering. He has directed several PhD on laser-assisted bioprinting for bone regeneration. From the years 2005, he participated in the first development of 3D bioprinting and was a pioneer in the field of in situ bioprinting. He is director of the ART BioPrint and the INSERM 1026 unit.
Trained as a biochemist, he has developed several engineering strategies, at the interface between chemistry and biology, to tackle unsolved problems in the field of nanotechnology and tissue engineering. He applies this know-how for bioprinting and biofabrication applications.